Fase 2
Quiénes somos
The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and Immunotherapy
Estudio de la ventana de oportunidad en el cáncer colorrectal
Dabrafenib + Trametinib + PDR001 en cáncer colorrectal
Un ensayo de ipatasertib en combinación con atezolizumab
Estudio de la plataforma TAPISTRY (Tumor-Agnostic Precision Immuno-Oncology and Somatic Targeting Rational for You)
Quimioembolización (Lifepearls-Irinotecan) en pacientes con cáncer colorrectal y enfermedad metastásica
Basket Combination Study of Inhibitors of DNA Damage Response, Angiogenesis and Programmed Death Ligand 1 in Patients With Advanced Solid Tumors
Linaclotide in Treating Patients With Stages 0-3 Colorectal Cancer
Phase I/II Trial of the Combination of Bintrafusp Alfa (M7824), Entinostat and NHS-IL12 (M9241) in Patients With Advanced Cancer
A Study of ALX148 With Cetuximab and Pembrolizumab for Refractory Microsatellite Stable Metastatic Colorectal Cancer
